Supplementary Figure S5 from Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017
crossref(2023)
摘要
Analysis of MEK and BRAF inhibitors approved before Nov. 2013 in a 102 cell line profiling
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要